Zobrazeno 1 - 10
of 192
pro vyhledávání: ''
Autor:
Yiping Wu, Lei Yang, Xin Li, Jin Ye, Jia Cong, Na Yao, Liqiang Wei, Xueying Cui, Jing Ding, Jingwen Wang, Jing Yang
Publikováno v:
Leukemialymphoma. 61(12)
We retrospectively analyzed the treatment outcomes of elderly patients (aged ≥ 60 years) with extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) and investigated the prognostic factors. Fifty-two elderly patients received chemotherapy al
Autor:
Francesco Merli, Luca Nassi, Monica Tani, Flavia Salvi, Vincenzo Pavone, Marco Ladetto, Manuela Zanni, Annalisa Peli, Stefano Volpetti, Riccardo Centurioni, Stefano Luminari, Annalisa Arcari, Alessandro Re, Michele Spina, Alessandro Pulsoni, Andrea Evangelista, Anna Marina Liberati, Alessandra Tucci, Roberto Freilone, Gerardo Musuraca, Caterina Patti, Caterina Stelitano, Stefania Massidda
Publikováno v:
Leukemialymphoma. 60(12)
This phase-II study assessed activity and toxicity of substituting conventional doxorubicin with nonpegylated liposomal doxorubicin in the conventional ABVD regimen for the treatment of elderly or cardiopathic patients with HL. Stage I-IIA and IIB-IV
Autor:
Nathan Fowler, Sweet Ping Ng, Bouthaina S. Dabaja, Jillian R. Gunther, Sarah A. Milgrom, Zeina Ayoub, T.Y. Andraos, Chelsea C. Pinnix, Felipe Samaniego, Luis Fayad, Sattva S. Neelapu, Loretta J. Nastoupil
Publikováno v:
Leukemialymphoma. 60(13)
Patients with early-stage nodal follicular lymphoma (FL) may be rendered free of detectable disease by a diagnostic excisional biopsy. We reviewed the management and outcomes of 48 patients with FL, diagnosed from 2003-2013, treated at a single insti
Autor:
Noah Kornblum, Diego Adrianzen Herrera, Aditi Shastri, Jesus D. Gonzalez-Lugo, Urvi A Shah, Olga Derman, B. Hilda Ye, Ana Acuna-Villaorduna, Murali Janakiram, R. Alejandro Sica, Amit Verma, Yanhua Wang, Ira Braunschweig, Benjamin Zalta, Nishi Shah, Ioannis Mantzaris
Publikováno v:
Leukemialymphoma. 60(13)
Lung involvement has been reported in HTLV-1 carriers and in patients with ATLL. Whether there are differences in the pattern of lung involvement between ATLL and HTLV carriers in North American patients is unknown. We aimed to compare CT pulmonary f
Autor:
Jennifer R. Brown, Philip C. Amrein, Philippe Armand, Jacob D. Soumerai, Lillian Werner, Ephraim P. Hochberg, Jeremy S. Abramson, Donna Neuberg, David C. Fisher, Matthew S. Davids
Publikováno v:
Leukemialymphoma. 60(12)
Bendamustine-rituximab (BR) is a standard therapy in CLL, and lenalidomide has single-agent activity. This phase 1 study evaluated lenalidomide-BR as initial CLL therapy. Thirteen patients were treated at three dose levels (DL), and an additional 10
Publikováno v:
Leukemialymphoma. 60(5)
Elderly patients with classical Hodgkin lymphoma (cHL) are understudied and poorly defined. The National Cancer Data Base was queried for adults with cHL diagnosed 2004-2013: 22,547 age 18-39, 12,841 age 40-59, and 10,873 age ≥60 were identified. T
Autor:
Yoshikazu Ito, Naoya Nakamura, Tetsuzo Tauchi, Seiichiro Katagiri, Yuko Tanaka, Hiroaki Fujimoto, Seiichi Okabe, Junko H. Ohyashiki, Chiaki Kawana, Seiichiro Yoshizawa, Kazuma Ohyashiki, Tomohiro Umezu, Tamiko Suguro, Michiyo Asano, Daigo Akahane, Yuu Saito, Kenichi Tadokoro, Moritaka Gotoh
Publikováno v:
Leukemialymphoma. 60(5)
Deletion polymorphism of BCL-2-like protein 11 (BIM) is specifically found in East Asia. To explain some epidemiological discrepancies between Asian and Western countries, we analyzed a silent single nucleotide polymorphism (SNP) in exon 5 (c465C T)
Autor:
Julio C. Chavez, Timothy J. Robinson, Sungjune Kim, Matthew N. Mills, Louis B. Harrison, Kamran Ahmed, C. Liveringhouse, G.D. Grass, Michael J. Montejo
Publikováno v:
Leukemialymphoma. 60(4)
We investigated whether adding radiation (RT) to systemic therapy improved outcomes in early stage diffuse large B-cell lymphoma (DLBCL) patients with or without double- or triple-hit lymphoma (DHL/THL) biology. This analysis included 183 patients pr
Autor:
Spencer B. Gibson, James B. Johnston, Danielle C Croucher, Barbara Sherry, Susi Snitzler, Anthea Lau, Ellen N Wei, Michelle Queau, Suzanne Trudel, David Spaner, Christine Chen, Sumeet Kakar, Lisa W. Le, Harminder Paul
Publikováno v:
Leukemialymphoma. 60(4)
Lenalidomide has anti-tumor activity in CLL but can be complicated by tumor lysis syndrome (TLS) and tumor flare (TF). In our previous study using low-dose lenalidomide in treatment-naive CLL, TLS was averted but TF remained frequent and complete res
Autor:
Wilfried Fehrle, Carsten Bokemeyer, Jakob Matschke, Anna Brandt, Mascha Binder, Gerald Illerhaus, Lisa von Wenserski
Publikováno v:
Leukemialymphoma. 60(2)
Clonal bone marrow (BM) B-cell populations are a common finding in patients with suspected primary central nervous system lymphoma (PCNSL). To assess their clinical significance, benign monoclonal B-cell lymphocytosis (MBL) needs to be differentiated